Please join Foley and Charles River Associates for a round table discussion with Zack Fang, member of the Chinese State Counsel Health Care Reform Expert Advisory Committee, and fellow panelists, to discuss:
- Myths about the Chinese health care system
- Competition and collaboration with local companies
- Opening China’s hospital market
- Price and market access issues faced by multinational pharmaceutical companies in China
Introduction
- Adria Warren, Senior Counsel, Foley & Lardner LLP
Moderator
- Dr. Elizabeth Xiao-Ru Wang, Principal, Charles River Associates
Panelists
- Dr. Jim Ewing, Partner, Foley & Lardner LLP
- Dr. Zack Fang, member of the Chinese State Counsel Health Care Reform Expert Advisory Committee
- Xiaolin Zhou, Partner, Jun He Law Offices
There is no cost to participate in this program; however, pre-registration is required. For additional information, please contact Delia Dai at ddai@foley.com.
People
Related Insights
24 April 2025
Foley Viewpoints
Prop 65: Changes to Short-Form Warnings Will Cause Long-Term Impacts
The California Office of Environmental Health Hazard Assessment recently amended its regulations concerning requirements for consumer product warnings to qualify for “safe harbor” protection from enforcement actions brought under the Safe Drinking Water and Toxic Enforcement Act of 1986, commonly known as Proposition 65.
24 April 2025
Tariff & International Trade Resource
What Every Multinational Company Should Know About … Customs Enforcement and False Claims Act Risks (Part II)
As detailed in Part I of our three-part series on Minimizing Customs Enforcement and False Claims Act Risks, the combination of the new high-tariff environment, the heightened ability of Customs (and the general public) to data mine, and the Department of Justice’s stated focus on using the False Claims Act substantially increases import-related risks.
24 July 2025
Events
ACI's Inaugural Summit on GLP-1 Law & Policy
Foley partner Kyle Faget, co-chair of the firm’s Medical Devices Area of Focus, is speaking in American Conference Institute’s Inaugural Summit on GLP-1 Law & Policy on July 24.